Table 1. Relationship beween UHRF1 expression, clinical and pathological features.
Clinical and pathological features | Total N | UHRF1 expression | P value | |
---|---|---|---|---|
Negative | Positive | |||
All cases | 160 | 120 | 40 | |
Mean age (years) ± SD | 65.9 ± 9.0 | 66.3 ± 9.4 | 65.0 ± 7.5 | 0.44 |
Sex | 0.49 | |||
Male | 139 | 103 | 36 | |
Female | 21 | 17 | 4 | |
Tumor location | ||||
Upper | 97 | 69 | 28 | 0.17 |
Lower | 63 | 51 | 12 | |
Tumor size (mm, mean ± SD) | 41.2 ± 20.7 | 40.6 ± 19.9 | 42.9 ± 23.6 | 0.64 |
T stage | 0.51 | |||
T1 | 84 | 66 | 18 | |
T2 | 21 | 16 | 5 | |
T3 | 54 | 37 | 17 | |
T4 | 1 | 1 | 0 | |
N stage | 0.24 | |||
Negative | 82 | 65 | 17 | |
Positive | 78 | 55 | 23 | |
Stage | 0.12 | |||
I | 55 | 47 | 8 | |
II | 57 | 38 | 19 | |
III | 42 | 31 | 11 | |
IV | 6 | 4 | 2 | |
Lymphatic invasion | 0.37 | |||
Negative | 113 | 87 | 26 | |
Positive | 47 | 33 | 14 | |
Venous invasion | 0.92 | |||
Negative | 79 | 59 | 20 | |
Positive | 81 | 61 | 20 |